These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21184155)

  • 1. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
    Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
    J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review.
    Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R
    Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID.
    Safaei S; Pourpak Z; Moin M; Houshmand M
    Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):129-32. PubMed ID: 21625022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
    Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
    J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
    Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
    Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
    Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
    Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell differentiation and IL-21 response in
    Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
    Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
    Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
    Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
    Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
    Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing of T
    El Hawary R; Meshaal S; Mauracher AA; Opitz L; Abd Elaziz D; Lotfy S; Eldash A; Boutros J; Galal N; Pachlopnik Schmid J; Elmarsafy A
    Clin Exp Immunol; 2021 Mar; 203(3):448-457. PubMed ID: 33040328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011).
    Yao CM; Han XH; Zhang YD; Zhang H; Jin YY; Cao RM; Wang X; Liu QH; Zhao W; Chen TX
    J Clin Immunol; 2013 Apr; 33(3):526-39. PubMed ID: 23250629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
    Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
    Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Genetic Defects in Severe Combined Immunodeficiency Patients from Turkey by Targeted Sequencing.
    Erman B; Bilic I; Hirschmugl T; Salzer E; Boztug H; Sanal Ö; Çağdaş Ayvaz D; Tezcan I; Boztug K
    Scand J Immunol; 2017 Mar; 85(3):227-234. PubMed ID: 28109013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
    Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
    Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
    Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
    J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe combined immunodeficiencies: Expanding the mutation spectrum in Turkey and identification of 12 novel variants.
    Aykut A; Durmaz A; Karaca N; Gulez N; Genel F; Celmeli F; Ozturk G; Atay D; Aydogmus C; Kiykim A; Aksu G; Kutukculer N
    Scand J Immunol; 2022 Jun; 95(6):e13163. PubMed ID: 35303369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.